HUMA- Humacyte, Inc.

Name: Humacyte, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Humacyte, Inc. (HUMA) has 4 insiders with recent SEC Form 4 filings, including 4 buys and 12 sells. HUMA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Parikh Shamik J	318.6K	$294.5K	-
CFO	Sander Dale A.	313.1K	$289.4K	-
CEO	Niklason Laura E	311.1K	$287.6K	-
Dir	Dougan Brady W	311.1K	$287.6K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 16, 2022	Ayabudge LLC	10% Owner	Sell	239,538	$2.53	$606,031.14	-1.3%	+14.1%	+24.1%
Dec 16, 2022	Dougan Brady W64	Director, 10% Owner	Sell	239,538	$2.53	$606,031.14	-1.3%	+14.1%	+24.1%
Dec 16, 2022	Sander Dale A.58	CFO And Chief Corp. Deve. Off.	Buy	20,000	$2.60	$52,000.00	+3,333%	+14.1%	+24.1%
Dec 15, 2022	Dougan Brady W64	Director, 10% Owner	Buy	10,000	$2.54	$25,400.00	+0.9%	+9.6%	+18.8%
Dec 15, 2022	Niklason Laura E65	President, CEO And Director	Buy	10,000	$2.54	$25,400.00	+0.9%	+9.6%	+18.8%
Dec 15, 2022	Ayabudge LLC	10% Owner	Sell	699,730	$2.78	$1,945,509.42	-1.3%	+9.6%	+18.8%
Dec 15, 2022	Dougan Brady W64	Director, 10% Owner	Sell	699,730	$2.78	$1,945,509.42	-1.3%	+9.6%	+18.8%
Dec 15, 2022	Niklason Laura E65	President, CEO And Director	Sell	699,730	$2.78	$1,945,509.42	-1.3%	+9.6%	+18.8%
Dec 13, 2022	Scheessele William John	Chief Commercial Officer	Buy	5,000	$3.09	$15,450.00	+47.5%	-5.7%	+3.2%
Sep 15, 2022	Niklason Laura E65	President, CEO And Director	Sell	1,522,500	$4.00	$6,090,000.00	-7.4%	-32.5%	-20.9%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC